Drawing for CUREBEST

USPTO serial 86247187

CUREBEST

Reviewed by CopyMark Law Group

Reg. 4714973Status 710
Filing date
Status date
Registration date
Apr 7, 2015
Examiner
WEIGLE, KATHERINE CONNOLLY
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CUREBEST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Philip A. Jones

PHILIP A. JONES BRINKS GILSON & LIONEPO BOX 10395CHICAGO, IL 60610-0395UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042medical testing and research services of genes, proteins and cells, and reporting of results for medical and scientific research purposes; providing laboratory research services in the field of gene expression; gene expression analysis service for others for medical and scientific research purposes; medical laboratory services, namely, clinical laboratory testing services and reporting of results for others for medical and scientific research purposes; providing medical and scientific research information regarding diagnostic testing results and disease conditions; scientific research for medical purposes in the area of cancerous diseases; medical research in the field of cancer diagnosis and cancer treatment; providing medical and scientific research information in the field of forecasting and predicting a recurrence of cancer; and analytic and diagnostic services for medical and scientific research purposes in the analysis of biological sample for forecasting and predicting a recurrence of cancerSECTION 8 - CANCELLED—
044Providing medical diagnostic services, testing and information in the field of cancer diagnosis; medical analyses, in particular, gene, protein and cell analyses for diagnosing cancer and forecasting the expected progress of a cancerous illness; gene, protein and cell analysis for medical diagnostic purposes; clinical laboratory testing service for medical diagnostic purposes specifically for forecasting and predicting a recurrence of cancer; and medical services, in particular laboratory testing services in the analysis of biological samples for medical diagnostic purposes specifically for forecasting and predicting a recurrence of cancer; providing information regarding medical diagnostic testing results and disease conditions for diagnostic purposesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 26, 2021C8..CANCELLED SEC. 8 (6-YR)—
Apr 7, 2020REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 7, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 20, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 20, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 31, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 13, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 10, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 9, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 9, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 30, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 30, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 29, 2014DOCKASSIGNED TO EXAMINER—
May 15, 2014AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
May 7, 2014ALIEASSIGNED TO LIE—
Apr 24, 2014MPMKNOTICE OF PSEUDO MARK E-MAILED—
Apr 23, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 22, 2014PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Apr 12, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance